Details for Patent: 9,133,461
✉ Email this page to a colleague
Which drugs does patent 9,133,461 protect, and when does it expire?
Patent 9,133,461 protects GIVLAARI and is included in one NDA.
This patent has fifty-four patent family members in twenty-seven countries.
Summary for Patent: 9,133,461
| Title: | Compositions and methods for inhibiting expression of the ALAS1 gene |
| Abstract: | The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1. |
| Inventor(s): | Bettencourt; Brian (Groton, MA), Fitzgerald; Kevin (Brookline, MA), Querbes; William (Cambridge, MA), Desnick; Robert J. (New York, NY), Yasuda; Makiko (New York, NY) |
| Assignee: | Alnylam Pharmaceuticals, Inc. (Cambridge, MA) Icahn School of Medicine at Mount Sinai (New York, NY) |
| Application Number: | 13/835,613 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; |
Drugs Protected by US Patent 9,133,461
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharms Inc | GIVLAARI | givosiran sodium | SOLUTION;SUBCUTANEOUS | 212194-001 | Nov 20, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF ACUTE HEPATIC PORPHYRIA | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,133,461
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 090641 | ⤷ Sign Up | |||
| Australia | 2013245949 | ⤷ Sign Up | |||
| Australia | 2018203098 | ⤷ Sign Up | |||
| Australia | 2020202970 | ⤷ Sign Up | |||
| Australia | 2024200975 | ⤷ Sign Up | |||
| Brazil | 112014025020 | ⤷ Sign Up | |||
| Canada | 2868290 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
